Martin Delaney, an advocate for people living with HIV/AIDS and co-founder of the treatment and education organization Project Inform, died on Friday at age 63 of liver cancer, the San Francisco Chronicle reports.

Virginia Commonwealth University researchers have found that the protein Stat3 plays a key role in regulating mitochondria, the energy-producing machines of cells. This discovery could one day lead to the development of new treatments for heart disease to boost energy in failing heart muscle or to master the abnormal metabolism of cancer. In the study, published online Jan.

A regular high-intensity, three-minute workout has a significant effect on the body’s ability to process sugars. Research published in the open access journal BMC Endocrine Disorders shows that a brief but intense exercise session every couple of days may be the best way to cut the risk of diabetes.

EUSA Pharma announced the launch of Caphosol, a medical innovation for the prevention and treatment of oral mucositis. Oral mucositis is one of the most common and debilitating side effects of cancer treatment 1 caused by radiotherapy or chemotherapy and affects approximately 115,000 people a year in the UK.

Oncolytics Biotech Inc. (”Oncolytics”) (TSX:ONC, NASDAQ: ONCY) announced that patient enrolment has begun in a U.K. translational clinical trial investigating intravenous administration of REOLYSIN(R) in patients with metastatic colorectal cancer prior to surgical resection of liver metastases. The principal investigator is Professor Alan Melcher of St. James’s University Hospital.

15.9 million euros project to improve drugs’ efficiency and minimize side effects Royal Philips Electronics is leading a major new European project to develop drug delivery technologies that could change the way treatment for cancer and cardiovascular disease is delivered.

Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low Perfusion pulse oximetry, announced that a new multi-center study of 39,821 newborns was published in the January 2009 issue of the British Medical Journal (BMJ).

The new antiepileptic drug Vimpat(R) (lacosamide) demonstrated significantly fewer seizures in adult partial-onset epilepsy patients whose seizures were inadequately controlled despite taking up to three other AEDs, according to a Phase III clinical study published online in Epilepsia.

The Sarcoma Foundation of America (SFA), an organization dedicated to increased research funding and advocacy for sarcoma, has named Jonathan Lewis, M.D., Ph.D. as the recipient of its 2009 Vision of Hope Award. Dr. Lewis is Chief Executive and Chief Medical Officer of ZIOPHARM Oncology, Inc. based in New York and Boston.

eResearchTechnology, Inc. (ERT), (Nasdaq: ERES), and Integrium, LLC announced their alliance to provide integrated Cardiac Safety and Ambulatory Blood Pressure Monitoring centralized core laboratory services to clinical trial sponsors and managers worldwide. eResearchTechnology is a leading provider of centralized electrocardiographic (ECG), eClinical technology, ePRO, and other services to the biopharmaceutical , medical device, and related industries.